Komatsu Yoshimichi, Fujimoto Keisaku, Yasuo Masanori, Urushihata Kazuhisa, Hanaoka Masayuki, Koizumi Tomonobu, Kubo Keishi
First Department of Internal Medicine, Shinshu University School of Medicine, Nagano, Matsumoto, Japan.
Respirology. 2009 Mar;14(2):217-23. doi: 10.1111/j.1440-1843.2008.01413.x.
More than 50% of patients with childhood asthma enter clinical remission by puberty, although 40-50% of these people will probably develop asthma symptoms during early adulthood. The mechanism of relapsing asthma in early adulthood remains unclear. This study determined the characteristics of young adults whose asthma remitted either during or before adolescence.
A comparative study was performed on 24 students whose childhood asthma had gone into clinical remission by puberty (remission group), 25 atopic students with no history of asthma (atopy group) and 19 non-atopic students without allergic diseases (control group). Examinations included spirometry, levels of serum-specific IgE-antibodies, airway responsiveness to methacholine, exhaled nitric oxide (eNO) and evidence of airway inflammation in induced sputum.
Airway responsiveness (P < 0.01), eosinophil counts in sputum (P < 0.05) and the prevalence of sensitization to Dermatophagoides forinae (P < 0.01) were significantly higher, and FEF(25-75%) and FEF(75%) (P < 0.01) were significantly lower in the remission group than in the atopy and control groups. Furthermore, 50% and 33% of the remission group had airway hyper-responsiveness (AHR) and sputum eosinophilia, respectively. The eNO levels in the remission (P < 0.01) and atopy (P < 0.05) groups were significantly higher than in controls. Remission group members with AHR had a significantly longer period of childhood asthma, a shorter period of remission and greater airway eosinophilic inflammation than those without AHR (P < 0.05).
One half of young adults with childhood asthma that remitted either during or before adolescence continued to have evidence of AHR and airway eosinophilic inflammation, and might be at risk of future relapse.
超过50%的儿童哮喘患者到青春期时进入临床缓解期,尽管其中40 - 50%的人在成年早期可能会出现哮喘症状。成年早期哮喘复发的机制尚不清楚。本研究确定了在青春期期间或之前哮喘缓解的年轻成年人的特征。
对24名儿童哮喘在青春期时进入临床缓解期的学生(缓解组)、25名无哮喘病史的特应性学生(特应性组)和19名无过敏性疾病的非特应性学生(对照组)进行了一项对比研究。检查包括肺量计检查、血清特异性IgE抗体水平、气道对乙酰甲胆碱的反应性、呼出一氧化氮(eNO)以及诱导痰中气道炎症的证据。
缓解组的气道反应性(P < 0.01)、痰中嗜酸性粒细胞计数(P < 0.05)以及对粉尘螨的致敏率(P < 0.01)显著更高,而用力呼气流量(FEF)(25 - 75%)和FEF(75%)(P < 0.01)显著低于特应性组和对照组。此外,缓解组分别有50%和33%的人存在气道高反应性(AHR)和痰嗜酸性粒细胞增多。缓解组(P < 0.01)和特应性组(P < 0.05)的eNO水平显著高于对照组。有AHR的缓解组成员的儿童哮喘病程显著更长,缓解期更短,气道嗜酸性粒细胞炎症比无AHR的成员更严重(P < 0.05)。
在青春期期间或之前哮喘缓解的年轻成年人中,有一半仍有AHR和气道嗜酸性粒细胞炎症的证据,可能有未来复发的风险。